Judge Says Janssen Alzheimer's Patent Invalid
By Erin Fuchs ( August 28, 2008, 12:00 AM EDT) -- A federal judge has ruled that Janssen Pharmaceutica Inc.'s Alzheimer's drug patent is invalid for lack of enablement in a victory for several generic-drug makers accused of infringing the patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.